gvtcx

NHS National Framework for Generic Pharmaceuticals - Sevoflurane and Vaporisers

COMMERCIAL MEDICINES UNIT Published 3 May 2016 Contracts Finder
The value below is a framework or dynamic market ceiling: the maximum that could be spent across all call-offs, not the value of a single contract. Aggregate figures on this site exclude these to avoid double counting.

key details

Value£26,000,000
Statuscomplete
Category (CPV) 33600000
RegionNorth East, North West, Yorkshire and the Humber, East Midlands, West Midlands, East of England, London, South East, South West
Deadline3 Jun 2016
Contract start25 Nov 2016
Contract end31 Mar 2019
Procedureopen
SME suitableYes
OCIDocds-b5fd17-9e94dc56-adc9-11e6-9901-0019b9f3037b

Award

SupplierValueDateStatus
Please see Document No 02 - Appendix 1 - Parties appointed to th £26,000,000 26 Jul 2016 active

description

NHS National Framework for Generic Pharmaceuticals - Sevoflurane and Vaporisers

Period of framework agreement: 32 months with the possibility of an extension of up to a further 16 months Potential periods of call-offs under the framework agreement: 1 August 2016 to 31 March 2019

documents

Documents are linked, not mirrored. They are served by the publishing authority and may require registration.

notice history

1 notice published against this procurement.

PublishedTypeRegimeNotice
25 Nov 2016 Award (award) · 8e7377ba-f7e2-40e3-b64e-bde300c71503-117679

more from COMMERCIAL MEDICINES UNIT

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.